| Code | 2325F | ||||||||||
| MA number | 68/0442/25-S | ||||||||||
| Product Form: | sus iph 1x100 mg (striek.inj.skl.napln.+2x ihla) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Exeltis Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 16.01.2026 |
| Validity: | 16.01.2031 |
| SPC: |
SPC_Psylipax_01_2026.doc
|
| PIL: |
PIL_Psylipax_01_2026.doc
|
| Safety feature | Yes |
| Data update: | 29.01.2026 |
